Taking peopleNo phase
Cardiac RadiothErapy for VEntricular Tachycardia II
Key facts
- Who runs it
- Universitaire Ziekenhuizen KU Leuven
- Where
- Belgium1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 50 people, planned
- Started
- 1 Jan 2025
- Expected to end
- Dec 2034
- Type of study
- Observational
- Treatments tested
- stereotactic radiotherapy ablation
- Record updated
- 29 April 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- Eligible for STAR for therapy-refractory VT based on a multidisciplinary discussion
- Ability to give a written informed consent and willingness to return for follow-up
Who cannot take part
- Contra-indications for STAR, including pregnancy or breastfeeding, previous radiotherapy with cardiac involvement, life-expectancy < 6 months in the absence of VT
- Any condition that is deemed a contraindication in the judgment of the investigators
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Steoreotactic therapy radioablation has become a standard of care option for patients with therapy-refractory ventricular tachycardia, yet long-term outcome is lacking. The objective of this study is to evaluate the long-term outcomes, both efficacy and safety, after STAR in patients with therapy-refractory ventricular tachycardia.
Treatments tested
- stereotactic radiotherapy ablation
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Cardiac RadiothErapy for VEntricular Tachycardia II - a Prospective Observational Cohort Study
- Record updated
- 29 April 2026